1 year return (CAGR)
-19.96%
NervGen Pharma Corp. Exchange (NASDAQ, USD)
NGEN
2.06
+0.07 (+3.77%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
10.51%
5 year return (CAGR)
3.37%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
222.03M
Price/Sales
-
Ent value
208.14M
Price/Book
12.83
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
17.41%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.00 |
| Daily high | 2.10 |
| Daily low | 1.99 |
| Daily Volume | 223K |
| All-time high | 5.97 |
| 1y analyst estimate | 10.00 |
| Beta | 0.69 |
| EPS (TTM) | -0.73 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NGEN | S&P500 | |
| Current price drop from All-time high | -65.41% | -0.58% |
| Highest price drop | -73.37% | -56.47% |
| Date of highest drop | 29 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -35.94% | -10.68% |
| Avg time to new high | 63 days | 12 days |
| Max time to new high | 556 days | 1805 days |
News
